Search Immortality Topics:

Page 55«..1020..54555657..6070..»


Category Archives: Nano Medicine

Manni’s Android Battle Command Defense 2/2 – Video


Manni #39;s Android Battle Command Defense 2/2
I #39;m playing Battle Command on my Samsung Galaxy Note 3. I uploaded two videos showing one big problem in the game: The fact that - when you #39;re offline - you ...

By: Manni-Gaming

Follow this link:
Manni's Android Battle Command Defense 2/2 - Video

Posted in Nano Medicine | Comments Off on Manni’s Android Battle Command Defense 2/2 – Video

Nano Medicine from "Development of Nanotechnology in Hong Kong" – Video


Nano Medicine from "Development of Nanotechnology in Hong Kong"
Nano Medicine from "Development of Nanotechnology in Hong Kong"From:XebecMediaLimitedViews:46 0ratingsTime:03:50More inPeople Blogs

Excerpt from:
Nano Medicine from "Development of Nanotechnology in Hong Kong" - Video

Posted in Nano Medicine | Comments Off on Nano Medicine from "Development of Nanotechnology in Hong Kong" – Video

2012 Deakin University 3 Minute Thesis Finalist – Jarrad Altimari – Video


2012 Deakin University 3 Minute Thesis Finalist - Jarrad Altimari
A 3MT presentation on a Nano medicine Approach to Prostate Cancer.From:deakinresearchViews:116 0ratingsTime:02:48More inEducation

View original post here:
2012 Deakin University 3 Minute Thesis Finalist - Jarrad Altimari - Video

Posted in Nano Medicine | Comments Off on 2012 Deakin University 3 Minute Thesis Finalist – Jarrad Altimari – Video

Deakin University – Practical Science – Nano medicine – Video


Deakin University - Practical Science - Nano medicine
http://www.deakin.edu.au An interview with Deakin University research fellow Dr Rupinder Kanwa as she discusses Deakin Uni #39;s groundbreaking Nano Medicine research Another one of many great reasons to come to Deakin University Open DayFrom:deakinuniversityViews:44 0ratingsTime:01:14More inEducation

More here:
Deakin University - Practical Science - Nano medicine - Video

Posted in Nano Medicine | Comments Off on Deakin University – Practical Science – Nano medicine – Video

New hope for leukemia patients

Kochi, Oct 15 (UNI)

Amrita Centre for Nanosciences and Molecular Medicine, part of the Amrita Institute of Medical Sciences and Research Centre has claimed to have discovered a potential cure for drug resistant leukemia.

Chronic Myeloid Leukemia (CML) responds well to a drug named 'Imatinib', however, when drug resistance sets in, which is in about 20-25 per cent of the cases, the patients has little chance of survival, a press release said here today.

Drug resistance was due to certain point mutations in the leukemia cells as a result of which the cells find an alternative pathway for survival, preventing the drug from killing the cancer cells, it said.

The Centre has developed a nanomedicine which had shown significant ability to kill the drug reststant cancer cells.

The nanomedicine was developed over the past three years and has shown success in in-vitro (or cell line based) studies, it added.

The Centre was now conducting animal trials or pre-clinical studies of the drug, it said, adding that it is expected that if pre-clinical trials are successful the new nano medicine can be submitted for clinical trial after approval from the government.

This was the first such discovery in the world of nanomedicine that effectively solves the problem of severe drug resistance in blood cancers.

The senior scientists involved in the research and development was Dr Manzoor Koyakutty, Professor and Dr Shantikumar Nair, Centre Director and Dean of Research.

Clinicians from the hospital who are involved in the research are Dr Pavithran, Dr Neeraj and Dr Prabhu. The PhD student who has worked on this as part of her PhD thesis is Archana Ratnakumari, it added.

See the original post:
New hope for leukemia patients

Posted in Nano Medicine | Comments Off on New hope for leukemia patients

NanoGuardian's On-Dose NanoEncryption Brand Protection Technology to Be Presented at AAPS Annual Meeting

SKOKIE, IL--(Marketwire - Oct 11, 2012) - NanoGuardian, a division of NanoInk, Inc. that delivers on-dose brand protection solutions to the pharmaceutical industry to fight counterfeiting and illegal diversion, announced today that it will give a poster presentation at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exhibition, which is being held on October 14 - 18, at McCormick Place in Chicago. The abstract, "Can Nanofabrication be used to Combat Counterfeit Medicines by Applying On-dose Authentication Features without Disrupting the Integrity of the Medicine?" will be presented on Monday, October 15, from 1:30 to 4:30 p.m. in Hall F by Bjoern Rosner, director of research and development, brand protection for NanoGuardian.

"Counterfeit medicines have become such a problem that pharmaceutical manufacturers are evaluating how to best ensure the integrity of their medicines for patients early in the drug development process," said Dean Hart, chief commercial officer of NanoGuardian. "The AAPS poster presentation will demonstrate that NanoGuardian's NanoEncryption technology can be used to incorporate highly sophisticated nanoscale, authentication, and tracing features directly on film-coated tablets, gelatin capsules, and vial caps without affecting the dissolution or stability of the medication -- important considerations in the development and commercialization of a new medication."

NanoGuardian's NanoEncryption technology is the only on-dose, multi-layered, brand protection solution that enables pharmaceutical manufacturers to authenticate and trace every single dose, from plant to patient. NanoGuardian's Closed-Loop Protection Program combines the on-dose authentication and tracing benefits of NanoEncryption technology with a proactive supply chain auditing program to identify counterfeit or illegally diverted pharmaceuticals entering the global supply chain as early as possible.

NanoGuardian fights both counterfeiting and illegal diversion with a single technology that can be used to protect capsules, tablets, vial caps, and single-use syringes providing a layered security of overt, covert, and forensic features. The overt and covert security features allow dose-level authentication at any point in the supply chain, while the forensic and nano-scale NanoCodes provide comprehensive tracing information on each and every dose. NanoGuardian's technology provides a strong benefit over other on-dose technologies given that NanoGuardian's security features are implemented with no additional material or chemicals being added to the medication.

As evidence of the rapidly growing problem of counterfeit pharmaceuticals, a recent report from the U.S. Customs and Border Protection and the U.S. Immigration and Customs Enforcement noted that the domestic value of counterfeit pharmaceutical seizures in fiscal year 2011 rose by more than $11 million, an increase of almost 200 percent. The implications for victims of counterfeit drugs are extremely serious, often resulting in unexpected side effects, severe allergic reactions and even death.

AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to health. It offers timely scientific programs, ongoing education, opportunities for networking, and professional development. More information is available at: http://www.aaps.org.

About NanoGuardian NanoGuardian, a division of NanoInk, Inc., focuses exclusively on delivering brand protection solutions to fight illegal diversion and counterfeiting. Anchored by NanoInk's novel NanoEncryption technology, NanoGuardian enables manufacturers to authenticate and trace the integrity of their products across the supply chain. More information about NanoGuardian is available at http://www.nanoguardian.net.

NanoInk, NanoGuardian, NanoEncryption and the NanoGuardian logo are trademarks or registered trademarks of NanoInk, Inc.

Go here to read the rest:
NanoGuardian's On-Dose NanoEncryption Brand Protection Technology to Be Presented at AAPS Annual Meeting

Posted in Nano Medicine | Comments Off on NanoGuardian's On-Dose NanoEncryption Brand Protection Technology to Be Presented at AAPS Annual Meeting